257 related articles for article (PubMed ID: 37987873)
1. Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP.
Guo CL; Liu FF; Wang DY; Liu Z
Curr Allergy Asthma Rep; 2023 Dec; 23(12):703-713. PubMed ID: 37987873
[TBL] [Abstract][Full Text] [Related]
2. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
Geng B; Dilley M; Anterasian C
Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
[TBL] [Abstract][Full Text] [Related]
3. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
[TBL] [Abstract][Full Text] [Related]
4. Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era.
Heffernan A; Phulka J; Thamboo A
J Otolaryngol Head Neck Surg; 2022 May; 51(1):22. PubMed ID: 35606866
[TBL] [Abstract][Full Text] [Related]
5. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
[TBL] [Abstract][Full Text] [Related]
6. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
[TBL] [Abstract][Full Text] [Related]
7. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
[TBL] [Abstract][Full Text] [Related]
8. Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.
Cavaliere C; Segatto M; Ciofalo A; Colizza A; Minni A; Messineo D; Lambiase A; Greco A; de Vincentiis M; Masieri S
Immunol Lett; 2022 Aug; 248():70-77. PubMed ID: 35752279
[TBL] [Abstract][Full Text] [Related]
9. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
Patel GB; Peters AT
Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
[TBL] [Abstract][Full Text] [Related]
10. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
Hardison SA; Senior BA
J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
[TBL] [Abstract][Full Text] [Related]
11. Study protocol: the biologics in severe chronic rhinosinusitis with nasal polyps survey.
Favier V; Daveau C; Carsuzaa F; Fieux M; Vandersteen C; Castillo L; Papon JF; de Gabory L; Saroul N; Verillaud B; Rumeau C; Jankowski R; Michel J; de Bonnecaze G; Lecanu JB; Coste A; Béquignon E; Malard O; Mortuaire G
BMJ Open; 2024 May; 14(5):e083112. PubMed ID: 38749694
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis.
Miglani A; Soler ZM; Smith TL; Mace JC; Schlosser RJ
Int Forum Allergy Rhinol; 2023 Feb; 13(2):116-128. PubMed ID: 35980852
[TBL] [Abstract][Full Text] [Related]
14. [Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics].
Hoffmann AS; Betz CS; Böscke R; Weber RK
HNO; 2024 Apr; 72(4):225-230. PubMed ID: 38376799
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation.
Jin Z; Yan B; Zhang L; Wang C
Expert Opin Investig Drugs; 2023; 32(10):909-919. PubMed ID: 37855222
[TBL] [Abstract][Full Text] [Related]
16. Otitis media in severe asthma associated with chronic rhinosinusitis with nasal polyps: a new therapeutic target for biologics.
Bartier S; Béquignon E; Thibaut de Ménonville C; Verillaud B; Evrard D; Léger M; Papon JF; Coste A; Taillé C
J Asthma; 2023 Jan; 60(1):139-144. PubMed ID: 35073225
[No Abstract] [Full Text] [Related]
17. Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis.
Cai S; Xu S; Lou H; Zhang L
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1876-1886.e7. PubMed ID: 35272073
[TBL] [Abstract][Full Text] [Related]
18. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
Dharmarajan H; Falade O; Lee SE; Wang EW
Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory infiltrate and mucosal remodeling in chronic rhinosinusitis with and without polyps: structured histopathologic analysis.
Kuhar HN; Tajudeen BA; Mahdavinia M; Gattuso P; Ghai R; Batra PS
Int Forum Allergy Rhinol; 2017 Jul; 7(7):679-689. PubMed ID: 28521083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
